The oncogenic fusion landscape in pediatric CNS neoplasms Mieke RoosenZelda OdéMarcel Kool Review Open access 15 February 2022 Pages: 427 - 451
Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations Laura de BoniAurelia Hays WatsonTim Bartels Original Paper Open access 09 February 2022 Pages: 453 - 469
Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis Matthew J. BroadheadCalum BonthronGareth B. Miles Original Paper Open access 19 March 2022 Pages: 471 - 486
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change Denis S. SmirnovNicholas J. AshtonDouglas Galasko Original Paper Open access 23 February 2022 Pages: 487 - 503
BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy Rui LiHao TangAmit Bar-Or Original Paper Open access 18 March 2022 Pages: 505 - 521
Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma Arnault Tauziède-EspariatLéa Guerrini-RousseauJulien Masliah-Planchon Correspondence Open access 23 February 2022 Pages: 523 - 525
Co-expression of APP/PS1 disrupts the distribution of brain lesions in a synucleinopathy transgenic mouse model (M83) Thierry BaronJean-Noël ArsacDominique Bétemps Correspondence 07 March 2022 Pages: 527 - 529